Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)
Price and Volume
Detailed Quote| Volume | 1,055,481 |
| Open | 58.52 |
| Bid (Size) | 58.04 (400) |
| Ask (Size) | 58.09 (200) |
| Prev. Close | 58.52 |
| Today's Range | 57.89 - 59.02 |
| 52wk Range | 34.63 - 64.38 |
| Shares Outstanding | 388,132,400 |
| Dividend Yield | 1.62% |
Top News
More News
Performance
More News
Read More
Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
Royalty Pharma Q2 Earnings Call Highlights ↗
August 05, 2026
Royalty Pharma reports second quarter 2026 results
August 05, 2026
Royalty Pharma declares third quarter 2026 dividend
July 17, 2026
3 Unpopular Stocks We’re Skeptical Of
June 12, 2026
Frequently Asked Questions
Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
The current price of Royalty Pharma plc - Class A Ordinary Shares is 58.06
When was Royalty Pharma plc - Class A Ordinary Shares last traded?
The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 09/23/26 01:45 PM ET
What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 22.53B
How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
Royalty Pharma plc - Class A Ordinary Shares has 23B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.